Germany to start COVID-19 vaccinations by mid-December

Tradingview chart of Astra Zeneca share price 23112020

Pfizer and Moderna's vaccines have already been shown to be effective, according to company data, and Gates said he expects AstraZeneca, Johnson & Johnson and Novavax's vaccines to have similar success soon.

The two companies concluded the Phase 3 trial of their COVID-19 vaccine candidate and announced that it met "all of the study's primary efficacy endpoints" and had a vaccine efficacy rate of 95 percent.

Pointing out that the urgency with which the vaccines had been developed must be matched with the urgency to distribute them fairly, he said, "Now the global community must set a new standard for access".

Brussels has already struck deals with AstraZeneca, Pfizer-BioNTech, Sanofi-GSK, Johnson & Johnson and CureVac.

Since AstraZeneca, Galvez said, is selling its vaccine through a non-profit model, it is now the cheapest, at only $5 per dose.


An EU official involved in the talks told Reuters last week the EU was seeking a price below $25 per dose for Moderna's vaccine. "The real question is not whether the world can afford to share vaccines and other tools; it's whether it can afford not to", he said.

He noted they will distribute it through a "geographical scheme" wherein they will prioritize areas, which have large incidents of Covid-19 such as the National Capital Region [NCR], Davao, Cebu and Bacolod.

The GAVI vaccine alliance on Tuesday welcomed Astrazeneca's interim data on efficiency of its COVID-19 vaccine, calling it "positive news for the COVAX vision of equitable access" for vulnerable groups worldwide. China is still conducting clinical trials of its experimental COVID-19 vaccine candidates in order to test their efficacy and safety. 80 per cent of the private health facilities have also shared their data.

The World Health Organization (WHO) defines herd immunity as a "concept of vaccination, in which a population can be protected from a certain virus if a threshold of vaccination is reached". And so our goal...to make sure that we have a vaccine that was accessible everywhere, I think we've actually managed to do that'. Countries around the world are also apparently in a race to bring out the most affordable vaccine. "The scientific community has set a new standard for vaccine development", Tedros added.

The Minister also said that the assessment of the vaccine stores has been completed. The third vaccine is expected to receive approval within this year.

Related:

Comments

Latest news

Russia Says Its Sputnik V Coronavirus Vaccine 95% Effective
The statement reported that the effectiveness of Sputnik-V exceeded 95 percent after 42 days of testing. Dr Reddy's will soon start its phase 2 and 3 clinical trial of the vaccine with 1,500 participants.

Brexit deal is achievable - Markey
The government said it paved the way for negotiations to begin next year on a new comprehensive deal with Canada. He said: "And, of course, there is also the small matter of free trade".

Square Enix to release Tomb Raider Reloaded for mobile devices in 2021
There will also be the classic traps within tombs as well as challenging puzzles to solve to progress through them. The iconic action-adventure games have entertained us for nearly 25 years now and there's another in the pipeline.

Biden Transition Formally Begins As Trump Says He Will Cooperate
By Monday, Biden had announced several key appointments and nominations for his national security and foreign policy team. Here's a brief insight into how the presidential transition process in the USA works.

More South Dakotans Choosing Not to Travel This Thanksgiving
To be sure, many Americans said they would do their best to conform with health recommendations. Still, many Americans are refusing to follow the health advice that could save their lives.

Other news